Clinical Trials Sponsored by Invatec S.p.A.

Total 772 results

Limacorporate S.p.a

Completed

Hip Arthroplasty With SL Cementless

Hip Replacement

Czechia
Philogen S.p.A.

Terminated

A Phase I/II Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Rituximab in Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Diffuse Large B-cell Lymphoma (DLBCL)

Germany
Philogen S.p.A.

Terminated

A Study of the Tumor-targeting Human F16IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Very Low-dose Cytarabine in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation

Acute Myeloid Leukemia, Relapsed, Adult

Germany
SOFAR S.p.A.

Completed

Multicentre Observational Study on the Wound Pain Relief Properties of ORTODERMINA®

Wound Healing Disorder

Italy
Kedrion S.p.A.

Completed

Efficacy/Safety of Human Plasminogen Eye Drop in Ligneous Conjunctivitis Patients

Ligneous Conjunctivitis

United States, Italy
SOFAR S.p.A.

Completed

Effect of a Combination of Hyaluronic Acid, Chondroitin Sulphate and Magnesium Trisilicate on Subjects With GastroEsophageal Reflux Disease

Gastro Esophageal Reflux

Belgium
Philogen S.p.A.

Active, not recruiting

A Phase I/II Dose Escalation Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Dacarbazine for Patients With Metastatic Melanoma

Metastatic Melanoma Stage IV

Italy, Germany
Philogen S.p.A.

Completed

L19TNFα in Combination With Doxorubicin in Patients With Advanced Solid Tumours

Advanced Solid Tumors Amenable to Anthracycline Therapy | Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer Amenable to Anthracycline Therapy

Germany, Italy
Limacorporate S.p.a

Completed

Prospective Observational Case Series of Primary Hip Arthroplasty With a Short Cemented Stem (Friendly Short)

Total Hip Arthroplasty

Italy
Limacorporate S.p.a

Active, not recruiting

Clinical Study Evaluating the Outcomes of a New Knee System With a Physiological Rollback Mechanism (K-06)

Primary Total Knee Replacement

United Kingdom, Italy
Limacorporate S.p.a

Completed

Physica KR Fluoroscopy Study

Total Knee Replacement

United Kingdom
SOFAR S.p.A.

Completed

Evaluation of GERDOFF Efficacy in Combination With Proton Pump Inhibitor

Gastro-oesophageal Reflux Disease

Italy
Alfasigma S.p.A.

Unknown

A Trial to Evaluate the Efficacy and Safety of PMF104 Compared to a Conventional PEG-electrolyte Solution in Children

Bowel Preparation Before Colonoscopy

Italy, Belgium, France
Limacorporate S.p.a

Completed

Fluoroscopic Analysis of Total Knee Replacement With a Kinematic Retaining or a Posterior Stabilized Design

Total Knee Replacement

Italy
SOFAR S.p.A.

Completed

Chemopreventive Action of Mesalazine on Colorectal Cancer: a Pilot Study for an "in Vivo" Evaluation of the Molecular Effects on β-catenin Signaling Pathway.

Colorectal Cancer

Italy
SOFAR S.p.A.

Completed

Efficacy Evaluation of a Commercial Preparation Containing Lactobacillus Casei DG on the Reduction of the Painful Symptoms Related to the Irritable Bowel Syndrome (IBS). A Pilot Clinical Study

Irritable Bowel Syndrome

Italy
Philogen S.p.A.

Completed

Intratumoral Application of L19IL2 in Patients With Malignant Melanoma

Malignant Melanoma

Austria, Germany
Philogen S.p.A.

Completed

131I-L19SIP Radioimmunotherapy (RIT) in Combination With External Beam Radiation in Patients With Multiple Brain Metastases From Solid Tumors

Brain Metastases From Solid Tumors

Italy, United Kingdom
SOFAR S.p.A.

Completed

Evaluation of Efficacy of Mesalamine in the Long-term Prevention of Diverticulitis Flares (DIV-01/04)

Diverticular Disease

Italy
SOFAR S.p.A.

Completed

Mesalazine Therapy in Patients With Irritable Bowel Syndrome (IBS-02/07)

Irritable Bowel Syndrome

Italy
Philogen S.p.A.

Terminated

Radioimmunotherapy With 131I-L19SIP in Patients With Cancer

Patients With Cancer

Italy, United Kingdom
ConvaTec Inc.

Not yet recruiting

Study to Demonstrate the Efficacy and Safety of Convatec ConvaFoam™ Silicone, ConvaFoam™ Border and ConvaFoam™ Non-adhesive Dressings to Protect Against Skin Breakdown (DONNA)

Skin Breakdown
ConvaTec Inc.

Completed

Observational Study to Investigate the Use of Sterilized Porcine Placental Tissue in the Treatment of Chronic VLU

Wound Heal | Ulcer Venous

United States
ConvaTec Inc.

Completed

GentleCath™ Air Intermittent Catheter Smartwatch Real Life Pilot Study

Neurogenic Bladder

United Kingdom
ConvaTec Inc.

Completed

A Prospective, Multi Centre, Interventional, Non-comparator, Open Label Study to Demonstrate the Efficacy, Performance and Safety of ConvaFoam™ Silicone, ConvaFoam™ Border and ConvaFoam™ Non-Adhesive Dressings in the Management of Surgical and Traumatic Wounds (MATILDA)

Surgical Wound | Trauma-related Wound

United States
ConvaTec Inc.

Completed

Comparison Study of 3 Ostomy Products

Ostomy

United States
ConvaTec Inc.

Completed

A Multi-centre Clinical Investigation to Assess the Performance of GentleCath™ Glide Intermittent Catheters

Comfort and Performance of Intermittent Catheter

Poland
ConvaTec Inc.

Completed

A Single Centre, Randomised, Comparative, Blinded Wear Test of Two Adhesives on the AQUACEL® Foam Adhesive Dressing

Safety and Performance of Dressing Adhesive on Healthy Volunteers

United Kingdom
ConvaTec Inc.

Unknown

User Evaluation of the Peristomal Skin Condition in Ostomates Using ConvaTec Moldable Technology™ (OSMOSE)

Colostomy | Ileostomy | Urostomy

Poland
ConvaTec Inc.

Completed

One Piece Drainable Pouch in Subjects With an Ileostomy

Ileostomy

United States
ConvaTec Inc.

Completed

One Piece Closed Pouch in Subjects With a Colostomy

Colostomy

United States
ConvaTec Inc.

Completed

Compare Aquacel® Ag Versus Mepilex® Border Ag to Manage Bioburden in Leg Ulcers

Leg Ulcers

United Kingdom
ConvaTec Inc.

Completed

EASH Dressing on Chronic Venous Leg Ulcers

Leg Ulcer

United Kingdom, Poland
Innate Pharma

Completed

Safety and Efficacy of Lacutamab in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma That Express KIR3DL2

Peripheral T Cell Lymphoma

Korea, Republic of, United States
Innate Pharma

Active, not recruiting

IPH4102 Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma (TELLOMAK)

Lymphoma, T-Cell | Lymphoma, T-Cell, Cutaneous | Mycosis Fungoides/Sezary Syndrome

United States, Spain, France, Italy, Belgium, Austria, Germany, Poland
Innate Pharma

Completed

Study of IPH4102 in Patients With Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL)

Cutaneous T-Cell Lymphoma

United States, France, Netherlands, United Kingdom
Innate Pharma

Terminated

Combination Study of IPH2201 (Monalizumab) With Ibrutinib in Relapsed, Refractory or Previously Untreated CLL

Chronic Lymphocytic Leukemia

United States
Innate Pharma

Completed

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR) (EFFIKIR)

Acute Myeloid Leukemia

France
Innate Pharma

Completed

An Open-label, Dose-escalation Safety and Tolerability Trial Assessing Anti-KIR (1-7F9) in Subjects With Multiple Myeloma

Multiple Myeloma

United States
Innate Pharma

Completed

Study on the Anti-tumor Activity, Safety and Pharmacology of IPH2101 in Patients With Smoldering Multiple Myeloma (KIRMONO)

Smoldering Multiple Myeloma

United States
Innate Pharma

Completed

A Safety and Tolerability Extension Trial Assessing Repeated Dosing of Anti-KIR (1-7F9) Human Monoclonal Antibody in Patients With Acute Myeloid Leukaemia

Acute Myeloid Leukemia

France
Innate Pharma

Completed

Study on the Safety, Anti-tumor Activity and Pharmacology of IPH2101 Combined With Lenalidomide in Patients With Multiple Myeloma Experiencing a First or Second Relapse (KIRIMID)

Patients With Multiple Myeloma Experiencing a | First or Second Relapse

United States
ConvaTec Inc.
NAMSA

Completed

AQUACEL® Ag+ Extra™ and Cutimed™ Sorbact® Dressing in the Management of Venous Leg Ulcers Over a 12-week Period

Diabetic Foot | Venous Leg Ulcer

Germany, Colombia, United Kingdom
ConvaTec Inc.
ClinSearch

Withdrawn

GentleCath Air (Urinary Self-catheterization) - Pain in Female Patients With Neurological Vesico-sphincter Disorders (FollowAir)

Multiple Sclerosis | Parkinsonian Disorders | Spinal Cord Injuries | Allodynia
Innate Pharma

Terminated

Efficacy Study of Pre-operative IPH2201 in Patients With Squamous Cell Carcinoma of the Oral Cavity

Squamous Cell Carcinoma of the Oral Cavity

Germany, Spain
Innate Pharma

Completed

Safety and Tolerability of NNC0141-0000-0100 in Subjects With Rheumatoid Arthritis

Inflammation | Rheumatoid Arthritis

Germany
Dompé Farmaceutici S.p.A

Recruiting

Study to Evaluate Corneal Neurosensory Abnormalities in Patients With Sjögren's Dry Eye (GEMINAE)

Dry Eye | Sjögren Syndrome

United States
Chiesi Farmaceutici S.p.A.

Recruiting

Effect of Erythromycin on the Absorption, Metabolism and Elimination of CHF6001 in Healthy Volunteers

Chronic Obstructive Pulmonary Disease

Bulgaria
Chiesi Farmaceutici S.p.A.

Recruiting

Comparison Between CHF5993 pMDI 200/6/12,5mg HFA-152a VS CHF5993 pMDI 200/6/12,5mg HFA-134a in Subjects With Asthma (Trecos) (TRECOS)

Asthma

United Kingdom
Fidia Farmaceutici s.p.a.

Recruiting

Evaluation of Performance and Safety of Eye Drops With Hydroxypropyl-methylcellulose and Inositol in Drye Eye Disease

Dry Eye Disease Associated to Asthenopia and Accommodative Effort in Video Display Terminal Users

Italy

3

Subscribe